Quest Diagnostics Launches SimplexaTM Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing – MarketWatch

Quest Diagnostics Incorporated DGX -0.11% , the worlds leading provider of diagnostic testing, information and services, today announced that the SimplexaTM Dengue molecular test kit developed by its Focus Diagnostics products business has been registered for distribution in Brazil. The test kit, from the award-winning Simplexa product line on the 3MTM Integrated Cycler, is the first commercial real-time polymerase chain reaction RT-PCR test to be approved for use by Brazils public and private health laboratories for testing for Dengue viruses.

via Quest Diagnostics Launches SimplexaTM Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing – MarketWatch.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s